Published in Med Hypotheses on April 01, 1979
The localization of Thy-1.1, MRC OX 2 and Ia antigens in the rat ovary and fallopian tube. Immunology (1983) 1.03
Immunoregulation of follicular renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis in vitro, POF and ovarian infertility treatment, and a clinical trial. Reprod Biol Endocrinol (2012) 0.91
Immune physiology in tissue regeneration and aging, tumor growth, and regenerative medicine. Aging (Albany NY) (2009) 0.87
Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases. Reprod Biol Endocrinol (2015) 0.78
The effect of the immune system on ovarian function and features of ovarian germline stem cells. Springerplus (2016) 0.75
Involvement of blood mononuclear cells in the infertility, age-associated diseases and cancer treatment. World J Stem Cells (2016) 0.75
Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol (1998) 8.21
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Functional domains of the capsid protein of human immunodeficiency virus type 1. J Virol (1994) 3.47
Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol (1995) 2.59
Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function. Mol Cell Biol (2001) 1.57
Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology (1996) 1.29
A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther (2001) 1.12
Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone (1987) 1.09
Activation of mitogen-activated protein kinases by gonadotropins and cyclic adenosine 5'-monophosphates in porcine granulosa cells. Biol Reprod (1996) 1.09
The localization of Thy-1.1, MRC OX 2 and Ia antigens in the rat ovary and fallopian tube. Immunology (1983) 1.03
Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Womens Health Gend Based Med (2001) 0.95
Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril (1999) 0.92
Melatonin rhythm in human milk. J Clin Endocrinol Metab (1993) 0.89
Fluorimetric estimation of oestrogen in the blood of infant female rats. J Endocrinol (1967) 0.87
Prospective trial of ossein-hydroxyapatite compound in surgically induced postmenopausal women. Bone (1989) 0.86
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol Med (1997) 0.86
[Agressive small cell carcinoma of the ovary, hypercalcemic type, surgery and oncological treatment: case report]. Ceska Gynekol (2015) 0.85
Signal transduction through the Ras/Erk pathway is essential for the mycoestrogen zearalenone-induced cell-cycle progression in MCF-7 cells. Mol Carcinog (2001) 0.84
Ovarian function in adult rats treated with antithymocyte serum. Experientia (1977) 0.83
The ovarian follicle as a model for the cell-mediated control of tissue growth. Cell Tissue Res (1984) 0.82
The role of the immune system in ovarian function control. Allergol Immunopathol (Madr) (1983) 0.82
Control of ovarian function by the immune system: commentary on the criticisms of Schenzle. Med Hypotheses (1981) 0.82
Expression of G1 cyclins and cyclin-dependent kinase-2 activity during terminal differentiation of cultured human trophoblast. Biol Reprod (1998) 0.81
Evidence for human chorionic gonadotropin binding sites in some organs of the immature female rat--effect of non-labelled chorionic gonadotropin and follicle-stimulating hormone on the distribution of 125-I-labelled human chorionic gonadotropin. Folia Morphol (Praha) (1971) 0.81
Cell-mediated and neural control of morphostasis. Med Hypotheses (1991) 0.81
Association of some cell surface antigens of lymphoid cells and cell surface differentiation antigens with early rat pregnancy. Immunology (1984) 0.80
Role of Thy-1+ and Ia+ cells in ovarian function. Biol Reprod (1986) 0.80
Oestrogen concentrations in blood of developing rats. J Endocrinol (1969) 0.80
Development changes in uptake of radioactivity by the ovaries, pituitary and uterus after 125 I-labelled human chorionic gonadotrophin administration in rats. J Endocrinol (1972) 0.79
Serum osteocalcin levels and bone alkaline phosphatase isoenzyme after oophorectomy and in primary hyperparathyroidism. J Clin Endocrinol Metab (1987) 0.79
Progesterone binding to lymphocytes-cause for transient loss of HLA antigens in women? Folia Haematol Int Mag Klin Morphol Blutforsch (1980) 0.79
The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone. Calcif Tissue Int (1989) 0.79
[Coronary heart disease with a marked vasospastic component associated with the menstrual cycle and its treatment]. Vnitr Lek (1995) 0.78
How closely are rat skeletal muscle development and regeneration processes related? Bibl Anat (1986) 0.77
Decrease in HCG--binding capacity of target tissues influenced by hypophysectomy. Endocrinol Exp (1973) 0.77
Ovarian morphology in congenitally athymic mice [proceedings]. Folia Biol (Praha) (1978) 0.76
[Origin of "definitive" oocytes in the mammal ovary]. Cesk Gynekol (1977) 0.76
Clinical findings with the oral contraceptive combination ethinylestradiol/dienogest in the Czech Republic. Methods Find Exp Clin Pharmacol (2002) 0.76
Effects of postnatal progesterone treatment on ovarian function in adult rats. Experientia (1979) 0.76
[Transdermal estradiol in the prevention of the menopause-induced increase in osteoresorption]. Cesk Gynekol (1989) 0.75
[Dealyed anovulatory syndrome after long-lasting progesterone administration in early postnatal period in the rat and its relation to follicular atresia (author's transl)]. Cesk Gynekol (1976) 0.75
[Errors in the diagnosis and treatment of the Stein-Leventhal syndrome]. Cesk Gynekol (1968) 0.75
[Mathematic modelling of the menstruation cycle]. Cesk Gynekol (1973) 0.75
[Our examination procedure in disorders of the menstruation cycle]. Cesk Gynekol (1969) 0.75
[Errors and possiblities of damage during treatment with gonadotropins]. Cesk Gynekol (1968) 0.75
[The effect of a "pure" gestagen on the uterine mucosa in functional hemorrhages]. Z Geburtshilfe Gynakol (1966) 0.75
[Brain cortex and genital cycle]. Cesk Gynekol (1971) 0.75
[Incorporation of chorionic gonadotropin I-131 into tissues of organism as manifested in experimental]. Cesk Gynekol (1970) 0.75
[Salt and late toxemia]. Cesk Gynekol (1968) 0.75
Developmental changes in concentration of pituitary luteinizing hormone after a single estrogen injection in female rats. Endocrinol Exp (1972) 0.75
[Genito-pituitary reflex]. Cesk Gynekol (1972) 0.75
[Adrenal glands and the so-called reactive hyperplasia of the endometrium in rabbits following oophorectomy]. Cesk Gynekol (1970) 0.75
[Mucopolysaccharide changes in the endometrium during the rise and drop of estrogen levels]. Cesk Gynekol (1966) 0.75
[Blood estrogens--dependency of values on the methods used]. Cesk Gynekol (1972) 0.75
[Blood estrogens in the so-called reactive endometrial hyperplasia of the oophorectomized rabbit]. Cesk Gynekol (1970) 0.75
[Urinary testosterone during the course of the menstrual cycle in normal women]. Cesk Gynekol (1972) 0.75
[Clinical classification of hypothalamohypophyseal disorders of the menstrual cycle]. Cesk Gynekol (1968) 0.75
[Decisive points in the development of regulatory mechanisms in the genital cycle of female rats]. Cesk Gynekol (1970) 0.75
[1st information on the clinical use of hypothalamic hormones in gynecology]. Cesk Gynekol (1970) 0.75
[Problems and prospects of research in menstrual cycle disorders]. Cesk Gynekol (1971) 0.75
Autoradiographic localization of radioactivity in female rat neocortex after injection of tritiated estradiol. Experientia (1971) 0.75
[New findings on human chorionic gonadotropin]. Cesk Gynekol (1972) 0.75
[17-ketosteroid excretion after proges- terone administration in the diagnosis of the Stein-Leventhal syndrome]. Zentralbl Gynakol (1966) 0.75
[Magnesium sulfate in the therapy of pre-eclampsia and eclampsia]. Cesk Gynekol (1970) 0.75
[Futurologic prediction on the development of biological sciences]. Cesk Gynekol (1970) 0.75
[Workshop meeting on the "Development of the Ovary", Birmingham, September 1969]. Cesk Gynekol (1970) 0.75
[Ball's suture in female urinary incontinence]. Cesk Gynekol (1968) 0.75
[Acylpyrin in gynecology and obstetrics]. Cesk Gynekol (1972) 0.75
[Changes in pituitary FSH concentration during early postnatal development and the effects of single estrogen injection in female rats]. Cesk Gynekol (1972) 0.75
Regional distribution of estrogenic metabolites in the female rat hypothalamus. Endocrinol Exp (1973) 0.75
Target organs of 131-I-chorionic gonadotrophine in immature female rat. Experientia (1970) 0.75
[Parotitis epidemica in the case history of women with menstruation disorders]. Zentralbl Gynakol (1968) 0.75
[New findings on hypothalamic hormones]. Cesk Gynekol (1973) 0.75
[Damage in the development of ovarian cycle regulatory mechanisms by human chorionic gonadotropin]. Cesk Gynekol (1973) 0.75
[Influence of adrenalectomy on the development of the so-called reactive endometrial hyperplasia in the oophorectomized rats]. Cesk Gynekol (1970) 0.75
[Hemostatic effect of a combination of mestranol and chlorsuperlutin in dysfunctional bleeding]. Cesk Gynekol (1969) 0.75
[Spontaneous menstruation in women with 45,XO-46,XX gonosomal mosaicism]. Cesk Gynekol (1972) 0.75
[Levels of total gonadotropic activity (TGA), urinary FSH, LH and estrogens of women in the prepubertal period]. Cesk Gynekol (1970) 0.75
[Observation of changes of the karyotype of women with the diagnosis of primary amenorrhea]. Cesk Gynekol (1969) 0.75
[Pneumopelvigraphy in the diagnosis and differential diagnosis of gonadal dysgenesis]. Geburtshilfe Frauenheilkd (1966) 0.75
[Prostaglandins]. Cesk Gynekol (1970) 0.75
[Brain cortex and estrogens]. Cesk Gynekol (1971) 0.75
[Uterine bleeding as a placebo effect]. Cesk Gynekol (1970) 0.75
[How to perform abortion in the 2d trimester]. Cesk Gynekol (1970) 0.75
[Pheromones in subhuman primates and in a man]. Cesk Gynekol (1972) 0.75
[Sexual maturation in girls with birth weight lower than 2000 g]. Cesk Gynekol (1973) 0.75
[Hypophysectomy and activity of 3-beta-hydroxysteroid dehydrogenase in the rat]. Cesk Gynekol (1970) 0.75
[Psychic factors in the etiology of dysfunctional bleeding]. Cesk Gynekol (1966) 0.75
[Treatment of dysfunctional bleeding]. Cesk Gynekol (1966) 0.75
Analysis of the postnatal development of the rat ovary by histochemical methods. Acta Histochem (1970) 0.75
[Utero-placental ischemia and late toxemia]. Cesk Gynekol (1968) 0.75
[Retroprogesterone and its derivatives--further possibilities for stimulation of ovulation in the woman]. Cesk Gynekol (1972) 0.75
[3-Beta-hydroxysteroid dehydrogenase activity in hypogonadotropic hypogonadism]. Cesk Gynekol (1967) 0.75
[Possible placebo effect in the progesterone test]. Cesk Gynekol (1970) 0.75
[Hormonal parameters in the anovulation cycle of the woman]. Cesk Gynekol (1973) 0.75
[Accumulation of radioactivity in the oocyte following 125 I-FSH administration]. Cesk Gynekol (1973) 0.75
[Treatment of the menstrual cycle disorders in a polyclinic center]. Cesk Gynekol (1972) 0.75
[Prostaglandins. II]. Cesk Gynekol (1970) 0.75
[The most frequent errorsduring estrogen therapy]. Cesk Gynekol (1968) 0.75